Skip to content

The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia

The Effects of Rhus Coriaria L. (Rhus or Somagh) on Serum Lipid Levels of Patients With Hyperlipidemia

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02295293
Acronym
SomaghLipid
Enrollment
74
Registered
2014-11-20
Start date
2014-12-31
Completion date
2015-05-31
Last updated
2016-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemias

Keywords

Rhus, Cholesterol, Triglycerides, Lipids, Medicine, Traditional, Herbal medicine

Brief summary

Coronary heart disease and stroke are two main causes of human deaths and is directly related to increased levels of plasma lipids.High total cholesterol and low high density lipoprotein cholesterol concentrations are often associated with endothelium dysfunction and inflammation, which can be followed by atherosclerosis. Rhus coriaria L. (Rhus) with the public name of Somagh is a plant species in the anacardiaceae family that is used as a food supplement, spice in Middle East region (Iran, Turkey and Arabic countries). In a double blind randomized placebo-controlled clinical trial, the investigators want to evaluate the effects of Somagh (Rhus coriaria L.) on serum lipid levels of patients with hyperlipidemia.

Detailed description

Rhus (Somagh) is found in temperate and tropical regions worldwide, often growing in areas of marginal agricultural capacity. Rhus is used as an herbal remedy in traditional medicine because of its assumed analgesic, antidiarrhetic, antiseptic, anorexic and antihypergylcemic properties. The fruits of Rhus contain flavonols, phenolic acids, hydrolysable tannins, anthocyans and organic acids such as malice, citric and tartaric acids. Some studies have shown that polyphenols could have beneficial effects on cardiovascular disease and cancer and could be regarded as bioactive compounds with a high potential health-promoting capacity. Phenolic compounds inhibit lipid peroxidation, scavenge the superoxide anion and hydroxyl radical, and enhance the activities of detoxifying enzymes.Moreover, the hypocholesterolemic action of dietary polyphenols has been reported. The hypocholesterolemic effect of Rhus fruit powder and its components have been reported previously in rabbits and mice.

Interventions

DRUGRhus Coriaria L. (Rhus)

500 mg of Rhus Coriaria L. (Rhus) powder in capsule: 1 capsule twice daily for 6 weeks

DRUGPlacebo

Placebo capsule: 1 capsule twice daily for 6 weeks

Sponsors

Shiraz University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age: 20-65 years * Serum triglyceride \>150mg/dl AND/OR total cholesterol \>= 240mg/dl

Exclusion criteria

* Serum triglyceride \> 500 mg/dl * Serum LDL-cholesterol at level which need drug treatment according to the patient risk categories (NCEP-ATP III) * Diabetes mellitus * Hypo. or hyperthyroidism * Any systemic illnesses e.g. liver cirrhosis, acute or chronic renal failure, heart failure * Use of drugs: OCPs, lipid lowering agents, thiazides * Pregnancy * Alcoholism * History of allergic reaction to Somagh

Design outcomes

Primary

MeasureTime frame
Serum triglyceride level6 weeks
Serum HDL-cholesterol level6 weeks
Serum total cholesterol level6 weeks

Secondary

MeasureTime frame
Serum ALT level6 weeks
Serum AST level6 weeks
Serum LDL-cholesterol level6 weeks
Number of patients with adverse events10 weeks
Serum alkaline phosphatase level6 weeks
Fasting Blood Sugar (FBS)6 weeks
Serum creatinin level6 weeks

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026